Updated May 19, 2016 This content is archived.
Jonathan F. Lovell, PhD, assistant professor of biomedical engineering, is interviewed about the promising biotech companies he has co-founded, Abcombi Biosciences, which boosts access to vaccines and allows the vaccines to work more efficiently, and POP Biotechnologies, which uses nanomedicine to find a more reliable way to deliver anti-cancer drugs to tumors.